Newborn Jaundice Treatment Market Analysis: How The Industry Is Evolving Toward A $3.49 Billion Future
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Newborn Jaundice Treatment Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The newborn jaundice treatment market size has demonstrated robust growth in recent years. This market is projected to expand from $2.71 billion in 2025 to $2.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.0%. Historically, this growth has been driven by the high prevalence of neonatal jaundice cases globally, limited availability of advanced phototherapy devices in low-resource settings, reliance on conventional fluorescent lamp-based treatment systems, delayed diagnosis of hyperbilirubinemia in newborns, and a lack of standardized neonatal screening protocols.
The newborn jaundice treatment market size is anticipated to expand significantly in the coming years, reaching $3.49 billion by 2030 with a compound annual growth rate (CAGR) of 5.3%. This forecasted growth can be linked to the increasing adoption of LED-based phototherapy systems, a greater focus on early neonatal screening programs, a rising demand for home-based newborn care options, advancements in non-invasive bilirubin monitoring technologies, and the worldwide expansion of neonatal intensive care infrastructure. Prominent trends for this period include LED-based intensive phototherapy systems for rapid bilirubin reduction in newborns, fiber-optic blanket phototherapy enabling continuous treatment with minimal infant disturbance, smart bilirubin monitoring systems integrated with real-time phototherapy adjustments, portable homecare phototherapy devices supporting early hospital discharge, and dual-surface phototherapy units enhancing treatment efficiency in neonatal intensive care.
Get A Free Sample Report With In-Depth Market Insights:
Newborn Jaundice Treatment Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The anticipated increase in birth rates is expected to drive the growth of the newborn jaundice treatment market moving forward. Birth rates indicate the number of live births within a specific population over a given period, reflecting overall demographic expansion and reproductive trends. This uptick in birth rates is fueled by improved maternal healthcare access, overall population growth, and supportive government initiatives in certain regions, resulting in a higher demand for postnatal care for newborns. Newborn jaundice treatment supports this trend by enabling early diagnosis and effective management of bilirubin levels in a growing neonatal population through phototherapy and related interventions, thereby minimizing the risk of complications. For instance, in July 2025, the Office for National Statistics, a UK-based government department, reported 594,677 live births in England and Wales in 2024, an increase of 3,605 (0.6%) compared to 2023, marking the first rise since 2021. Therefore, rising birth rates are a significant driver for the growth of the newborn jaundice treatment market.
Newborn Jaundice Treatment Market Segment Analysis: What Are The Core Market Categories?
The newborn jaundice treatment market covered in this report is segmented –
1) By Device Type: Overhead Phototherapy Units, Portable Phototherapy Units, Other Device Types
2) By Modality: Conventional Phototherapy, Light Emitting Diode Phototherapy, Fiber Optic Phototherapy
3) By Service Type: Diagnostic And Screening Services, Therapeutic And Nursing Services, Support And Monitoring Services
4) By Technology: Light Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic
5) By End User: Hospitals, Neonatal Intensive Care Units, Pediatric Clinics, Homecare Settings
Subsegments:
1) By Overhead Phototherapy Units: Light Emitting Diode Overhead Phototherapy Units, Fluorescent Lamp Overhead Phototherapy Units, Halogen Lamp Overhead Phototherapy Units, Double Surface Overhead Phototherapy Units
2) By Portable Phototherapy Units: Wearable Phototherapy Blanket Units, Fiber Optic Phototherapy Pad Units, Portable Light Emitting Diode Phototherapy Units, Compact Handheld Phototherapy Units
3) By Other Device Types: Phototherapy Bassinet Systems, Phototherapy Incubator Integrated Systems, Combination Phototherapy And Warming Units, Multisurface Phototherapy Systems
Newborn Jaundice Treatment Market Innovation Trends Shaping Future Development
Leading companies in the newborn jaundice treatment market are increasingly focusing on advanced non-invasive screening solutions, particularly smartphone-based bilirubin detection technologies, to enable earlier diagnosis and improve the accessibility of care. Smartphone-based bilirubin detection operates by using mobile imaging and algorithm-based analysis of skin coloration to estimate bilirubin levels without requiring blood sampling or specialized equipment. A key development occurred in July 2024, when Konica Minolta, a Japan-based technology company, partnered with Picterus AS, a Norway-based digital health company, to enhance non-invasive jaundice screening solutions. This collaboration leverages smartphone-based imaging to facilitate early detection, enhance accessibility in low-resource settings, and support timely intervention while ensuring screening accuracy. Additionally, this solution diminishes dependence on hospital-based diagnostic tools and enables point-of-care screening within community and home settings, further supporting scalable neonatal screening programs by offering healthcare providers a cost-effective, user-friendly technology.
Newborn Jaundice Treatment Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the newborn jaundice treatment market are Koninklijke Philips N. V., GE HealthCare Technologies, Drägerwerk AG & Co. KGaA, Heal Force Bio-Meditech Holdings Limited, Atom Medical, Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Geräte GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc., Cobams Srl, Kay & Company, Nareena Lifesciences Private Limited, Alfamedic, Delta
View The Full Newborn Jaundice Treatment Market Report:
Newborn Jaundice Treatment Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the newborn jaundice treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the newborn jaundice treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
